Skip to main content

2023 AGENDA

Friday, February 24th, 2023

6:00 – 7:00 PM Welcome Reception  South Ballroom
7:00 – 9:30 PM Welcome Dinner with Keynote Speaker-  Climate Change: Our Role as Health Care Providers Dr. Maura Brown- South Ballroom

Saturday, February 25th, 2023

7:00 – 7:50 AM Breakfast Kerrisdale Ballroom
7:55 – 8:00 AM BCGU Welcome Dr. Krista Noonan- GUTG Systemic Chair- South Ballroom

Prostate Session 1: Localized PC – Session Chairs: Dr. Iain McAuley and Dr. Charmaine Kim Sing

All Sessions include 25% of Time for Question Periods and Audience Participation 

8:00 – 8:20 AM Optimal Workup of Local Disease: Transperineal Biopsy, PSMA PET Dr. Miles Mannas
8:20 – 8:40 AM Localized High Risk Disease: Optimal Dose Escalation of RT Dr. David Kim
8:40 –  9:00 AM High Risk Localized PC: Is the Addition of ARAT to ADT+RT Now Standard? Dr. Mira Keyes
9:00 – 9:30 AM Debate: Has PSMA PET Significantly Helped with Patient and Treatment Selection in the Salvage Setting Post Prostatectomy? NO PSMA PET:  Dr. Michael Peacock
YES PSMA PET:  Dr. Justin Lee
9:30 – 9:50 AM Panel Discussion and Cases: High Risk Pathologies : Management of Local and Metastatic Disease  (Intraductal /Cribriform) Panelists: Dr. Jeff McCracken, Dr. Gang Wang, Dr. Ryan Urban & Dr. Cal Andreou
9:50 – 10:10 AM Genetic Testing: When, Whom, How, Why? Dr. Alex Wyatt
10:10 – 10:30 AM PMSA PET Positive versus Conventional Imaging Positive: Implications Dr. Scott Tyldesley
10:30 – 10:50 AM Health Break & Networking

RCC Session – Session Chairs: Dr. Andrew Attwell and Dr. Vu Truong

All Sessions include 25% of Time for Question Periods and Audience Participation 

10:50 – 11:10 AM Panel Discussion and Cases: Management of Growing Renal Masses: SBRT vs Surgery vs RFA Chair: Dr. John Kinahan
Panelists: Dr. Mike Eng, Dr. David Liu & Dr. Howard Pai
11:10 – 11:30 AM Debate: Adjuvant Immunotherapy: To Give or Not To Give PRO: Dr. Jesse Shustik
CON:  Dr. Lyly Le
11:30 – 11:50 AM Cytoreductive Nephrectomy: Upfront or Delayed (and When to Refer Back) Dr. Brian Yang
11:50 – 12:10 PM First-line mRCC: Triplet Versus Doublet ? Dr. Joanna Vergidis
12:10 – 12:30 PM Oligometastases / Oligoprogression: Role of Local Treatment Intensification Dr. Soha Atallah
12:30 – 12:45 PM VHL Disease: Novel Management Options Dr. Maryam Soleimani
12:45 – 1:45 PM LUNCH / Networking / Exhibition

Testis Cancer Session – Session Chairs: Dr. Param Bains and Dr. Ian Wright

All Sessions include 25% of Time for Question Periods and Audience Participation 

1:45 – 2:05 PM miRNA 371 – A New Biomarker ? Dr. Lucia Nappi
2:05 – 2:25 PM IGCCCG Poor Risk Choriocarcinoma – An Oncologic Emergency. Dr. David Telio
2:25 – 2:45 PM Surgery for Early Stage Metastatic Testis Cancer – Ready for Prime Time ? Dr. Matthew Ho
2:45 – 2:50 PM Closing Remarks for Day 1 Dr. Chris Hoag – BCUS Chair
7:00 PM Dinner/Reception Paradox Hotel- Kerrisdale Room

Sunday, February 26th, 2023

7:00 – 8:00 AM Breakfast  Centre Foyer/South Ballroom

8:00 – 8:05 AM

 

Welcome -Dr. Jack Zheng GUTG RT Chair Dr. Jack Zheng – GURG RT Chair – South Ballroom

Bladder Cancer Session – Session Chairs: Dr. Ardashes Avanessian and Dr. Alym Abdulla

All Sessions include 25% of Time for Question Periods and Audience Participation 

8:05 – 8:25 AM Evolving Medical Management of Non-muscle Invasive UC Dr. Michael Metcalfe
8:25 – 8:45 AM Bladder Preservation and Trimodal Therapy: Indications and Approaches Dr. Nathan Wong
8:45 – 9:05 AM Neoadjuvant Chemotherapy: ddMVAC vs cis/gem Dr. JM Lavoie
9:05 – 9:25 AM Debate: ctDNA Should Be Used to Guide Adjuvant IO After Radical Cystectomy PRO: Dr. Corinne Maurice Dror
CON: Dr. Richard Gagnon
9:25 – 9:45 AM Biomarker Directed Therapies: HER-2, FGFR, ADCs Dr. Daniel Khalaf
9:45 – 10:05 AM Treatment Sequencing in Metastatic Disease Dr. Bernie Eigl
10:05 – 10:25 AM Panel Discussion and Cases: Upper Tract UC Management: Panelists: Drs. Dinesh Samarasekera, Stacy Miller, Michael Humphreys & Richard Gagnon
10:25 – 10:50 AM Health Break / Networking / Exhibition / Check-out

Prostate Cancer Session 2: mCRPC – Session Chairs: Dr. Dylan Narinesingh

All Sessions include 25% of Time for Question Periods and Audience Participation 

10:50 – 11:10 AM mCSPC: Doublet or Triplets Dr. Simon Yu
11:10 – 11:30 AM PARP Inhibitors: Selected or Unselected Patient Population? Dr. Sunil Parimi
11:30 – 11:50 AM Treatment Sequencing in the Era of Lutetium Dr. Kim Chi
11:50 – 12:10 PM Management of Oligometastatic Disease: Metastasis Directed Therapy? ADT? RT to Primary? Dr. Jim Ddamba
12:10 – 12:15 PM BCGU Conference Closing Remarks Dr. Christian Kollmannsberger